FindTrial
Sign In

Prostatic artey embolization as a primary treatment for benign prostatic hyperplasia

Prostatic artey embolization as a primary treatment for benign prostatic hyperplasia

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800014818
Enrollment
Unknown
Registered
2018-02-07
Start date
2018-02-03
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

benign prostatic hyperplasia

Interventions

treatment team: prostate artery emblization
control team:transurethral resection prostate

Sponsors

Tianjin First Center Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
50 Years to 100 Years

Inclusion criteria

Inclusion criteria: The diagnostic criteria were diagnosed as prostatic hyperplasia by the 2014 Chinese urological disease diagnosis and treatment guidelines.

Exclusion criteria

Exclusion criteria: The exclusion criteria were for patients with clear surgical and anaesthetic contraindications.

Design outcomes

Primary

MeasureTime frame
prostate volume;maximum flow rate;operation time;blood loss;complication;—

Countries

China

Contacts

Public ContactWu Jianhui

Tianjin First Center Hospital

wjh9877@163.com+86 18920439916

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026